Youcai Zhang——Professor |
|
|
Nationality:
|
CHINA
|
|
Phone:
|
022-87401830
|
|
Email:
|
youcai.zhang@tju.edu.cn
|
|
Office:
|
Room 3107, Building 24, Tianjin University
|
|
School:
|
School of Pharmaceutical Science and Technology
|
|
ResearcherID:
|
|
|
Group weblink
|
|
Education Experience
| 2011 | Ph. D. Pharmacology and Toxicology | University of Kansas Medical Center |
| 2013-2014 | Postdoctoral Bioengineering | University of California San Francisco |
Professional Experience
| 2011-2013 | Associate Scientist | Elan Pharmaceutics Inc |
| 2013-2014 | Principle Scientist | Apricity Therapeutics |
Research Area
Honors and Awards
| Associate Editor, Toxicological Sciences |
| Editor board member, Journal of Lipid Research |
Patents
Highlighted Publications
| Xu T, Li X, Zhao W, Wang X, Jin L, Feng Z, Li H, Zhang M, Tian Y, Hu G, Yue Y, Dai X, Shan C, Zhang W, Zhang C, Zhang Y. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis, Journal of Experimental&Clinical Cancer Research, 2024 |
| Zhao W, Wang X, Han L, Zhang C, Wang C, Kong D, Zhang M, Xu T, Li G, Hu G, Luo J, Yee SW, Yang J, Stahl A, Chen X, Zhang Y. SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis, Nature Communications, 2024 |
| Hui Xiong, Chunze Zhang, Lifeng Han, Tong Xu, Khawar Saeed, Jing Han, Jing Liu, Curtis D. Klaassen, Frank J Gonzalez, Yuanfu Lu, Youcai Zhang, Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron-induced hepatotoxicity, Hepatology, 2022 |